A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

Donate Today Your gift will immediately help to educate, empower, and support individuals and communities on bone health and in the risk-reduction and treatment of osteoporosis. Donate Cook With OC […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]

Osteoporosis Canada continues to advise Canadians to meet the Institute of Medicine established daily calcium requirement of 1000 -1200 mg, from dietary sources preferably, and to use supplements if this […]

Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]

General Information About Pain After A Fracture Pain is the body’s natural response when a bone breaks. Both the fracture and any injuries to the body tissue near the fracture […]

Available Volunteer Opportunities Call for Nominations – Board of Directors Osteoporosis Canada (OC), a registered charity, is the only national organization serving people who have, or are at risk for, […]